Most Serious Complication of Aplastic Anemia
The most serious complication of aplastic anemia is invasive fungal infection, particularly invasive pulmonary aspergillosis, which accounts for the majority of infection-related deaths and carries a mortality rate exceeding 90% in patients with severe neutropenia.
Mortality Impact
Infection represents the leading cause of death in aplastic anemia patients, accounting for approximately 55-62% of all deaths 1, 2. Within this category, invasive fungal infections—predominantly aspergillosis and candidiasis—have emerged as the primary killers, responsible for 30% of all secondary infectious events but 55% of fatal infectious complications 1.
Why Fungal Infections Are Most Lethal
The devastating nature of invasive aspergillosis in aplastic anemia stems from several factors:
- Extremely high mortality: 90% fatality rate even with treatment 1
- Occurs despite empirical antifungal therapy: Invasive pulmonary aspergillosis develops even when patients receive prophylactic amphotericin B 1
- Fatal pulmonary hemorrhage: 77% of patients with invasive pulmonary aspergillosis die from catastrophic pulmonary bleeding 1
- Requires bone marrow recovery for survival: Without hematologic recovery, prognosis is universally grave 1
Risk Factors for Fatal Complications
The degree and duration of neutropenia directly correlates with infection risk and mortality 3, 2, 4:
- Absolute neutrophil count <0.2 × 10⁹/L: Associated with more frequent and severe infections 4
- Prolonged severe neutropenia: Single most important risk factor for invasive mycoses 1
- Severe monocytopenia: Independent predictor of fungal infection development 1
Other Life-Threatening Complications
While infection dominates mortality, other serious complications include:
Hemorrhage
- Accounts for 7% of deaths when occurring alone 1
- However, 56% of infection-related deaths have concomitant hemorrhage 1
- Particularly catastrophic when combined with invasive aspergillosis
Clonal Evolution
- Develops at constant rate after diagnosis (50% within first 30 months if it occurs) 5
- Chromosome 7 abnormalities: Most ominous, associated with leukemic transformation and death 5
- Complex cytogenetic abnormalities: Poor prognosis similar to monosomy 7 5
- Trisomy 8 has more favorable prognosis than other clonal changes 5
Clinical Implications
Aggressive antimicrobial prophylaxis is essential 6, 7. The 2026 ASH guidelines specifically recommend antibiotic and antifungal prophylaxis in neutropenic patients, recognizing that infection prevention is critical to survival.
Early definitive therapy is paramount: The high mortality from invasive fungal infections underscores why prompt hematopoietic stem cell transplantation or immunosuppressive therapy to restore marrow function is life-saving 6, 7.
Common Pitfall
Do not underestimate the lethality of mold infections in aplastic anemia. Unlike bacterial infections which respond to antibiotics, invasive aspergillosis has dismal outcomes regardless of antifungal therapy without bone marrow recovery 1. This makes restoration of hematopoiesis through transplant or immunosuppression the only truly effective intervention.
The prevalence of infection in aplastic anemia reaches 86% 4, but it is specifically the invasive fungal infections—not the more common bacterial infections—that determine survival 2, 1.